The University of Michigan Scleroderma Program is a multidisciplinary group of care givers, scientists and clinical researchers dedicated to advancing knowledge about scleroderma and related conditions. Our mission is to provide local, national and international leadership in advancing the treatment of scleroderma and related conditions, through excellence in clinical care, teaching and research. The overarching goal of the Program is to develop effective therapies for the disease and its complications.
CORE elements are:
- Clinical care with emphasis on cost-effective outpatient management
- Outreach to the community of patients and physicians
- Research into the cause, mechanisms and treatment
- Education of physicians and allied health professionals
The goals of the Scleroderma Program are to develop effective therapies for scleroderma and its complications and to research the causes and mechanisms of disease. It is only through enhanced understanding of disease process that a cure will be possible.